GDR — Genedrive Share News
0.000.00%
- £9.06m
- £3.89m
- £0.50m
REG - AIM - AIM Notice - 03/06/2024
AnnouncementREG - Genedrive PLC - Block listing returns
AnnouncementREG - Genedrive PLC - Result of General Meeting
AnnouncementREG - Genedrive PLC - Result of Open Offer and REX Offer
AnnouncementREG - Genedrive PLC - Initial orders of the Genedrive MT-RNR1 Products
AnnouncementREG - Genedrive PLC - Key CYP2C19-ID test performance milestone achieved
AnnouncementREG - AIM - AIM Notice - 15/05/2024
AnnouncementREG - Genedrive PLC - Amendment to Open Offer timetable
AnnouncementREG - Genedrive PLC - Publication of Circular and Notice of GM
AnnouncementREG - Genedrive PLC - Completion of placing
AnnouncementREG - Genedrive PLC - Proposed Fundraise for a minimum of £6.0 million
AnnouncementREG - Genedrive PLC - Proposed REX Retail Offer
AnnouncementREG - Genedrive PLC - Clinical Trial Agreement
AnnouncementREG - AIM - AIM Notice - 09/04/2024
AnnouncementREG - Genedrive PLC - Application for Listing & Total Voting Rights
AnnouncementREG - Genedrive PLC - NICE recommends the Genedrive CYP2C19-ID Kit
AnnouncementREG - Genedrive PLC - Half-year Report
AnnouncementRCS - Genedrive PLC - Investor presentation
AnnouncementREG - Genedrive PLC - Application for Listing & Total Voting Rights
Announcement